← Alle mensen

HK

Hiromitsu Kumada

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non...
Lancet (London, England) · 18 januari 2025
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo bij HCC: LEAP-002 fase III
The Lancet. Oncology · 2023-12